Skip to main content

FDA Honors APF Executive Director, Desiree Lyon Howe




FDA Honors APF Executive DirectorDesiree Lyon Howe
  

   Desiree

 Our very own APF Executive Director receives a great honor.....

 January 4, 2013 will mark the 30th Anniversary of the enactment of theOrphan Drug Act. In recognition of this important legislation and accomplishments of members of the rare disease community in their efforts to support and develop treatments for individuals with rare diseases, the Federal Drug Administration plans to highlight 30 Heroes who have made clinical, research, advocacy and regulatory contributions over these many years.

 The Office of Orphan Products Development (OOPD) plans to showcase the 30 Heroes on January 7, 2013 during a program that includes invited presenters such as Commissioner HamburgFrances Collins, Director, NIH;Representatives Henry Waxman and Orrin Hatch, or their designees; Peter Saltonstall, CEO, NORD; and Abbey Meyers, as well as former and current OOPD staff.

 One of these Heroes is Desiree Lyon HoweCo-Founder and Executive Director of the American Porphyria Foundation, who spoke in front of Congress to support the Orphan Drug Act and helped bring Panhematin® to the forefront of the first Orphan drug.  Panhematin® was the first orphan designated drug to receive marketing approval in 1983.  It is used to relieve recurrent attacks of acute intermittent porphyria (AIP) and other acute porphyrias.  In acute porphyrias, an important part of hemoglobin called heme is not made properly, causing varying symptoms with the most common being severe abdominal pain.   Desiree was 17 years old when she had her first attack and suffered many years undiagnosed.  In 1982 she was given experimental hemin at the National Institutes of Health, tremendously improving her quality of life.  She continues to be an active rare disease advocate today.

  Congratulations to Desiree Lyon Howe, and thank you to all of you who have volunteered for the ongoing porphyria studies. Each and every participant is helping us all get closer to better treatment, and a cure for Porphyria.

Remember.... Research is the key to your cure!

Comments

Popular posts from this blog

GLOBAL PORPHYRIA ALLIANCE

GLOBAL PORPHYRIA ALLIANCE The APF is proud to support our members that live across the globe. Many countries around the world have developed organizations to support their local communities. We hope that enjoy the same opportunity to communicate with one another, develop friendships, and learn about porphyria. Here are links to patient advocacy groups worldwide that offer support to individuals impacted by porphyria. Argentina: Centro de investigaciones sobre porfirinas y porfirias | More informationAustralia: Porphyria Association, Inc. | More informationBrazil: Associação Brasileira de Porfiria | More informationCanada: Canadian Association for Porphyria | More informationColombia: Fundación Colombiana Para La Porfiria | More informationDenmark: Porfyriforeningen.dk (Porphyria Association Denmark)Denmark: Porfyrier.dk (Danish Porphyria Support Group)England: British Porphyria AssociationFinland: Finnish Porphyria Support Group France: Association Française des Malades Atteints de Por…

WHAT IS NEUROPATHIC PAIN?

What could it be?
Nerve Pain WHAT IS NEUROPATHIC PAIN? Neuropathic or nerve pain (NP) is a long-term or chronic pain disease that results from nerve damage. It can be caused by different diseases or conditions. Worldwide nerve pain affects as many as 26 million people. Neuropathic or nerve pain may affect larger areas of the body or it can be restricted to a smaller area, in this case it is called localized neuropathic pain (LNP). WHAT CAUSES NEUROPATHIC PAIN? Neuropathic or nerve pain may occur in the absence of an obvious visible cause (e.g. an accident, an injury, a chemical burn). There are several external situations that can directly damage nerves and lead to neuropathic pain, such as: Amputation of a limb (phantom pain, stump pain)Surgery (scar pain, post-surgery pain)Trauma or accident Neuropathic pain is also a common complication of other diseases, including nerve damage after shingles or herpes zoster infection (postherpetic neuralgia or PHN), nerve damage after HIV infectio…

Happy Winter Season!

                  Happy Winter Season!